Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) Growth (3y) (2023 - 2025)

Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) Growth (3y) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (3y) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 59.54%
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 22,777.33%
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1,857.10%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 41.33%
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 14.33%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Palvella Therapeutics 1.42 Bn 1.16 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -83.14%
Mar 31, 2025 -119.47%
Dec 31, 2024 42.98%
Sep 30, 2024 -154.15%
Jun 30, 2024 -114.58%
Mar 31, 2024 -180.20%
Dec 31, 2023 332.40%
Sep 30, 2023 -222.24%
Jun 30, 2023 248.21%